FITC-Labeled Recombinant Human B7-H3/CD276 Protein
Artikelnummer:
ABB-RP00635FLQ
Produktübersicht
Artikelname:
FITC-Labeled Recombinant Human B7-H3/CD276 Protein
Artikelnummer:
ABB-RP00635FLQ
Hersteller Artikelnummer:
RP00635FLQ
Alternativnummer:
ABB-RP00635FLQ-100UG
Hersteller:
ABclonal
Wirt:
Human
Kategorie:
Proteine/Peptide
Spezies Reaktivität:
Human
Immunogen:
Leu29-Pro245
Alternative Synonym:
B7H3, B7-H3, CD276, PSEC0249, UNQ309, PRO352, B7 homolog 3, CD276
Produktbeschreibung
B7-H3, a member of the B7 family of immunomodulatory molecules, is overexpressed in a wide range of solid cancers.B7-H3 binds to activated T cells via an as yet unidentified receptor. In assays using sub-optimal amount so anti-CD3 stimulation, 2Ig?B7?H3 enhances T cell proliferation, T cell interferon-gamma (IFN-gamma) production, and cytotoxic T cells induction.
Produkteigenschaften
Konzentration:
< 1 EU/µg of the protein by LAL method.
Molekulargewicht:
50.1 kDa
NCBI:
80381
UniProt:
Q5ZPR3
Reinheit:
95 % as determined by SDS-PAGE.
Formulierung:
Supplied as 0.22 µm filtered solution in PBS (pH 7.4).
Sequenz:
LEVQVPEDPVVALVGTDATLCCSFSPEPGFSLAQLNLIWQLTDTKQLVHSFAEGQDQGSAYANRTALFPDLLAQGNASLRLQRVRVADEGSFTCFVSIRDFGSAAVSLQVAAPYSKPSMTLEPNKDLRPGDTVTITCSSYRGYPEAEVFWQDGQGVPLTGNVTTSQMANEQGLFDVHSVLRVVLGANGTYSCLVRNPVLQQDAHGSVTITGQPMTFP
Target-Kategorie:
B7-H3/CD276
Anwendungsbeschreibung
Application Verdünnung:
Supplied as 0.22 µm filtered solution in PBS (pH 7.4).
Anwendungsbeschreibung:
ResearchArea: Biosimilar Drug Targets, Bio-Markers & CD Antigens
Bilder
FITC-Labeled Recombinant Human B7-H3/CD276 Protein was determined by Tris-Bis PAGE under reducing conditions.